CME Information

Target Audience

This conference is designed for interventional cardiologists, cardiac and vascular surgeons, nurse practitioners and physician assistants, interventional radiologists and other healthcare professionals interested in the optimal practice of interventional and structural cardiovascular medicine.

Activity Purpose

Cardiovascular practice has never evolved more rapidly than today as cardiologists and surgeons collaborate to offer exciting new options for percutaneous and minimally invasive hybrid therapies. Arteries, valves, veins, infracting, hypertrophied myocardium and other anatomic sites are targets for intervention and symptom relief in a vast array of cardiovascular pathology including STEMI, unstable angina/non-STEMI, cardiogenic shock, aortic stenosis, mitral regurgitation, acute stroke, claudication and limb salvage, chronic valvular and perivalvular defects and many other conditions including adult congenital heart disease. This course will feature the cumulative wisdom of 20 academic centers with live case demonstrations, lectures, presentations and discussions of complex cases, debates between well-known interventionalists and surgeons and the opportunity for insightful audience participation and discussion. The national concern regarding appropriate selection for diagnostic studies and intervention will be addressed in detail. The conference will feature joint sessions as well as dedicated tracks for coronary and structural/peripheral intervention.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Recognize the efficiency of novel techniques and review current state-of-the-art approaches to the optimal practice of coronary, structural, and peripheral interventions
  • Explain the improvement in clinical outcomes following optimal percutaneous and surgical management of complex coronary artery disease, including chronic total inclusions, cardiogenic shock, and cardiac arrest
  • Discuss the next generation drug-eluting stents and drug-eluting balloons, and how they can prevent the leading causes of stent failure, which are stent thrombosis, stent restenosis, and neoatherosclerosis
  • Review safety and efficacy of transcatheter aortic, mitral, and tricuspid valve replacements and repairs in high- and intermediate-risk patients
  • Evaluate the prevalence of microvascular and vasospastic disease and describe their novel pharmacologic interventions
  • Appraise the safety and efficacy of ventricular assist devices in heart failure
  • Summarize novel catheter based treatments of cardiac arrhythmias
  • Explain the indications for invasive physiologic (FFR, iFR) and imaging assessment (IVUS, OCT) of lesion severity to determine optimal revascularization strategies
  • Review developments in therapies related to left atrial appendage occlusion
  • Describe the mechanisms of action and clinical applicability of lipid-lowering agents for primary or secondary prevention of coronary artery disease

Accreditation & Credit Designation

The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This activity is approved for AMA PRA Category 1 Credit™.

2017 Commercial Support

EPIC-SEC 2017 was supported by educational grants from the following companies:

  • Abbott
  • Abiomed
  • ACIST Medical
  • Amgen
  • Boston Scientific
  • Chiesi USA
  • Edwards Life Sciences
  • Gilead Sciences
  • Medtronic
  • Philips Volcano
  • Toshiba
  • Vascular Solutions